报价延迟最少15分钟:2025/08/24 23:46 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.09 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.44/--
|
|
企业价值
116.32M
|
| 资产负债 |
|
每股账面净值
0.19
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
52.35M
|
|
每股收益
1.25
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/08/24 23:46 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue. |
